Atlas Trials

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality

Clinical trial NCT06706232 · RECRUITING

Trial details

NCT number
NCT06706232
Sponsor
The University of Texas Health Science Center, Houston
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar II DisorderDepression, BipolarSuicidality
Start date
2025-07-07
Primary completion
2027-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.